Michael A. Pickert, PMHNP
NPI 1275090300ActiveIndividual· Nurse Practitioner, Psych/Mental Health· Irvington, AL
Nurse Practitioner, Psych/Mental Health (PMHNP) with New South Psychiatry, PC, practicing in Irvington, Alabama. Part D covered 896 prescriptions written in 2024, 96% of them generic. Axsome Therapeutics, Inc. was the largest of 15 companies reporting payments in 2025, $2,643 in all, mostly food and beverage.
Overview
| NPI | 1275090300 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | PMHNP |
| Sole proprietor | No |
| NPI issued | Feb 25, 2019 |
| Last updated in NPPES | Dec 27, 2021 |
| Certified by provider | Dec 27, 2021 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Nurse Practitioner, Psych/Mental Health Primary | 363LP0808X | 1-143378 | AL |
| Nurse Practitioner, Family | 363LF0000X | 1-143378 | AL |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Nurse Practitioner (AL) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 896 · 1,474 30-day fills |
|---|---|
| Patients | 69 |
| Total drug cost | $99,157 |
| Generic share | 96% of claims |
Education and affiliations
| Graduation year | 2018 |
|---|---|
| Medicare specialty | Nurse Practitioner |
Medical group
- New South Psychiatry, PCMobile, AL · 5 clinicians
Industry payments (Open Payments)
- 2025$2,643 · 107 payments from 15 companies
- 2024$1,139 · 47 payments from 12 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Axsome Therapeutics, Inc. | $440.75 | 13 |
| Iti, Inc. (D/B/A Intra-Cellular Therapies, Inc.) | $396.36 | 11 |
| Abbvie Inc. | $395.36 | 28 |
| Neurocrine Biosciences, Inc. | $365.18 | 10 |
| E.R. Squibb & Sons, L.L.C. | $193.83 | 6 |
What the 2025 payments were for
- Food and Beverage$2,643 · 107 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records